Official US documents have disclosed that a popular anti-stroke medicine may have used fictitious data while concealing research on its fatal effects. In 2009, the acclaimed British medical journal, The Lancet, published a prime story on rivaroxaban, a blood thinner medicine, which showed that the treatment was safe and efficient.

UK: Lancet opens probe into ‘unreliable’ anti-stroke medicine taken by millions worldwide

rivaroxaban

Rivaroxaban, News on Rivaroxaban, stories on Rivaroxaban, articles on Rivaroxaban, Rivaroxaban stories at Wion, Rivaroxaban news, Rivaroxaban latest news